● Case studies Real-time oversight. Proactive problem-solving. Full commitment to your success. Case Study Ph2 single arm Breast Cancer No patient recruitment in the 1st year of a Global Clinical Study Learn more Case Study Large Pharma Ph3 Pivotal Lymphoma study for potential Registration based on Overall Response Rate and Duration of response. Identification of incorrect endpoint Adjudication during the study Learn more Case Study Ph2 study for a rare Disease that was planned to be supportive for a registration PH3 Pivotal study Lack of critical documentation during trial Learn more Case Study FIH Ph1 Solid tumor study. Entry criteria requires either mutation or gene amplification. Discovery that critical inclusion pathological criteria was not met Learn more Case Study Ph2 NSCLC study with safety as primary endpoint Discovery of Inadvertent mixture IP from other lot/study Learn more
Case Study Ph2 single arm Breast Cancer No patient recruitment in the 1st year of a Global Clinical Study Learn more
Case Study Large Pharma Ph3 Pivotal Lymphoma study for potential Registration based on Overall Response Rate and Duration of response. Identification of incorrect endpoint Adjudication during the study Learn more
Case Study Ph2 study for a rare Disease that was planned to be supportive for a registration PH3 Pivotal study Lack of critical documentation during trial Learn more
Case Study FIH Ph1 Solid tumor study. Entry criteria requires either mutation or gene amplification. Discovery that critical inclusion pathological criteria was not met Learn more
Case Study Ph2 NSCLC study with safety as primary endpoint Discovery of Inadvertent mixture IP from other lot/study Learn more
